$BXRX - Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery (12/8/2022): https://finance.yahoo.com/news/baudax-bio-initiates-phase-ii-130000290.html
$HOTH - FDA Signs Off Hoth Therapeutics' Trial Application For HT-001 For Skin Cancers: https://finance.yahoo.com/news/fda-signs-off-hoth-therapeutics-140828045.html
$KALA - Wall Street Analysts Predict a 268% Upside in Kala Pharma (KALA): Here's What You Should Know: https://finance.yahoo.com/news/wall-street-analysts-predict-268-145502640.html
$NUWE - SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medical’s Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI): https://finance.yahoo.com/news/seastar-medical-nuwellis-enter-u-183500231.html